Immunohistochemical analysis of KI67 on tumor tissues showed that DCs stimulated by 6Gy*3f-TEXs, Osimertinib, and their combination significantly reduced tumor growth and malignancy compared to other treatments (Figure 6F). This evidence concerns the gene MKI67 and neoplasm.